izpis_h1_title_alt

Primerjava izbranih postopkov (mikro)kapsuliranja železa
ID Jaklič, Laura (Author), ID Zvonar Pobirk, Alenka (Mentor) More about this mentor... This link opens in a new window, ID Devjak, Rok (Comentor)

.pdfPDF - Presentation file. The content of the document unavailable until 12.04.2025.
MD5: 7BFE33D85159D49D01FC3CC7B257A4CD

Abstract
Železo predstavlja enega najpomembnejših oligoelementov v našem telesu, anemija zaradi pomanjkanja železa pa je najpogostejša oblika anemije. Kljub temu, da peroralno nadomeščanje železa velja za najbolj varno, učinkovito in cenovno ugodno zdravljenje, veliko težavo predstavljajo neželeni učinki na prebavni trakt. Bruhanje, driska, zgaga in bolečine so pogosto vzrok za nesodelovanje pacientov pri zdravljenju. Med druge možnosti zdravljenja umeščamo še parenteralno nadomeščanje železa, ki pa se ga navadno poslužimo šele v primeru, ko se pacient ne odziva na peroralno zdravljenje ali ob določenih bolezenskih stanjih. Ker je pojavnost neželenih učinkov v primeru peroralnih farmacevtskih oblik s podaljšanim sproščanjem znatno manjša, so številne raziskave usmerjene v odkrivanje novih tehnoloških pristopov za doseganje želenega profila sproščanja železa. V magistrski nalogi smo želeli doseči podaljšano sproščanje vodotopne oblike železa (Fe-glukonat) s postopkom (mikro)kapsuliranja. Pri tem smo se poslužili metode ekstruzije lamelarnega curka tekočine z vibrirajočo membrano (tako imenovan postopek ionotropnega geliranja), postopka koacervacije in direktne adsorpcije v/na mezoporozne nosilce oz. granuliranja z emulzijami. Naš cilj je bil predvsem izdelava produktov v trdnem agregatnem stanju z visoko vsebnostjo vodotopnega Fe-glukonata in s prirejenim sproščanjem vgrajene spojine. V ta namen smo izdelanim formulacijam določili vsebnost Fe in profile sproščanja v kislem (pH=1,2) in nevtralnem (pH=6,8) mediju. Za primerjavo smo izbrane formulacije izdelali tudi s slabo vodotopno obliko Fe-pirofosfata. Koncentracijo železa v vzorcih smo določali spektrofotometrično s spremljanjem nastanka obarvanega kompleksa z 1,10 – fenantrolinom pri izbrani valovni dolžini. Za najuspešnejši način (mikro)kapsuliranja z vidika upočasnitve sproščanja vodotopne spojine se je izkazala metoda z vibrirajočo membrano. Z direktno adsorpcijo disperzije na mezoporozni nosilec Syloid® 244 FP nismo uspeli podaljšati sproščanja Fe. V nasprotju s pričakovanji prav tako ne moremo potrditi zadržanega sproščanja iz koacervatov, medtem ko smo z metodo emulgiranja s sledečo granulacijo nekoliko upočasnili sproščanje vodotopne Fe-spojine. Kljub pridobljenim rezultatom obstaja še veliko prostora za nadaljnje raziskave, izboljšanje in optimizacijo postopkov za dosego željenega profila sproščanja.

Language:Slovenian
Keywords:železo, prirejeno sproščanje, (mikro)kapsuliranje
Work type:Master's thesis/paper
Organization:FFA - Faculty of Pharmacy
Year:2024
PID:20.500.12556/RUL-155740 This link opens in a new window
Publication date in RUL:14.04.2024
Views:459
Downloads:0
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Comparison of selected iron (micro)encapsulation techniques
Abstract:
Iron is one of the most important elements in our body and its deficiency leads to the most common type of anemia, known as iron deficiency anemia. While oral iron supplementation is the safest, most efficient and cost-effective intervention, it often leads to gastrointestinal side effects such as vomiting, diarrhoea, heartburn and abdominal pain, which can contribute to poor patient compliance. If the patient does not respond to oral treatment or in certain medical conditions, parenteral administration can be used as an alternative. As oral dosage forms with a sustained iron release profile are associated with fewer adverse effects, many studies have focussed on developing new technological approaches to achieve the desired iron release profile. In this master thesis, we aimed to utilise the process of (micro)encapsulation to achieve a prolonged release of the water-soluble form of iron (i.e. Fe-gluconate). For this purpose, the (co-)extrusion of a lamellar liquid jet with a vibrating nozzle technology (in combination with the ionotropic gelation process) was used in addition to the coacervation method, direct adsorption on mesoporous carriers and the emulsion-based wet granulation process. Our primary objective was to produce a solid (powdered) formulation with a high content of water-soluble Fe-gluconate and with a modified release of the encapsulated compound. The iron content and release profiles of the manufactured products were evaluated in acidic (pH=1,2) and neutral (pH=6,8) media. For comparison, counterparts with poorly water-soluble Fe-pyrophosphate were prepared for some formulations. The iron concentration in the prepared samples was determined spectrophotometrically by observing the formation of a coloured complex with 1,10–phenantroline at a specific wavelength. While the vibrating nozzle technology was most effective in slowing down the release of the water-soluble Fe-gluconate, we were unable to prolong the release using the direct adsorption technique based on the mesoporous carrier Syloid® 244 FP. Contrary to our expectations, coacervates also failed to release Fe-gluconate over a longer period of time, while its release was slightly slowed down from granules prepared using the emulsion-based wet granulation method. However, there are other options that could be tested in the future to improve and optimise the technological approaches to achieve the desired release profile.

Keywords:iron, prolonged release, (micro)encapsulation

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back